Summary, initial outputs and next steps Collaboration for Applied Health Research &amp; Delivery

Squire, S. Bertel

doi:10.1186/1753-6561-9-s10-s1

BMC Proc

2015

DOI: 10.1186/1753-6561-9-s10-s1

|View full text |Cite

Summary, initial outputs and next steps Collaboration for Applied Health Research & Delivery

S. Bertel Squire

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients’ perspective

Oliveira

Gallo

Bastos

et al. 2021

Transactions of the Royal Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Background Although rare, Guillain-Barré Syndrome (GBS) has a high economic burden, with consequences for families and society. This study aimed to estimate the total cost of GBS, per individual and per variant of the disease, as well as its effect on household income, from the perspective of patients. Methods This was a cost-of-illness study from the perspective of patients and their families, with a time horizon from disease onset to 6 mo after discharge. The total cost of GBS was estimated by bottom-up microcosting, considering direct and indirect costs. Results The median cost of GBS per individual was US$1635.5, with direct costs accounting for 64.3% of this amount. Among the variants analyzed, acute motor sensory axonal neuropathy (US$4660.1) and acute inflammatory demyelinating polyneuropathy (US$2017.0) exhibited the highest costs compared with acute motor axonal neuropathy (US$1635.5) and Miller Fisher Syndrome (US$1464.8). The costs involved compromise more than 20% of the household income of 22 (47.8%) patients. Conclusions This study demonstrated how costly GBS can be. It is hoped that decision-makers will analyze these results with a view to improving the structure of healthcare services.

show abstract

Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients’ perspective

Oliveira

Gallo

Bastos

et al. 2021

Transactions of the Royal Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Summary, initial outputs and next steps Collaboration for Applied Health Research & Delivery

Cited by 1 publication

References 23 publications

Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients’ perspective

Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients’ perspective

Contact Info

Product

Resources

About